Skip to content

Cardiovascular health follow-up of patients with prostate cancer: a single-center, ambispective cohort study

Cardiovascular health follow-up of patients with prostate cancer: a single-center, ambispective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067963
Enrollment
Unknown
Registered
2023-02-01
Start date
2021-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Group of prostate cancer:None

Sponsors

The Second Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Prostate cancer (PCa) patients present at the Urology Clinic of the Second Hospital of Tianjin Medical University. 2. PCa Patients who were pathologically diagnosed through prostate biopsy or postoperative results, or clinically diagnosed based on imaging and other data due to contraindication of puncture or surgery. 3. Accept the baseline cardiovascular health assessment. 4. Perform a serum prostate-specific antigen (PSA) test and agree to keep the remaining blood samples. 5. Good compliance and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other types of tumors. 2. Patients who were considered unsuitable to participate in the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events (MACE; non-fatal stroke, non-fatal myocardial infarction, or cardiovascular death);

Secondary

MeasureTime frame
Prostate cancer related death;All-cause death;Electrocardiogram;Metabonomics;

Countries

China

Contacts

Public ContactYong Wang

The Second Hospital of Tianjin Medical University

wy@tmu.edu.cn+86 15122286696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026